EHA: European Hematology Association

Conference Coverage

Combo delays progression in relapsed CLL

VIENNA—Results of the COMPLEMENT 2 trial indicate that adding ofatumumab to treatment with fludarabine and cyclophosphamide (OFC) can improve some...

Conference Coverage

Unsickling red blood cells

VIENNA—Researchers say they have found a way to unsickle red blood cells (RBCs), at least in vitro. Using pegylated carboxyhemoglobin bovine gas...

Conference Coverage

mAb produces responses in AL amyloidosis

VIENNA—A monoclonal antibody (mAb) can produce responses in patients with light chain (AL) amyloidosis and persistent organ dysfunction, according...